MegaRobo Technologies has raised nearly $200 million in a round joined by Oman Investment Authority, the company announced November 18. It plans to use the money to expand its AI-driven scientific research business internationally and develop core technology.

Manufacturing generated 68.3% of the Chinese company's 2024 revenue, against 31.7% from smart laboratories, according to Leidi's June 2025 report on its Hong Kong listing application, published by Sina.

MegaRobo sells systems combining robots, scientific instruments and software for tasks such as antibody selection and molecular screening. Customers can also commission research from its automated laboratory, 36Kr reported. Its industrial systems detect defects and monitor quality in semiconductor, optical-interconnect and display manufacturing.

Asia Investment Capital, Granite Asia and Sinovation Ventures invested again in the latest round, alongside new participant CMB International, according to the company. MegaRobo previously announced an approximately $300 million Series C in June 2022, co-led by Goldman Sachs Asset Management, Asia Investment Capital and GGV Capital.

MegaRobo applied for a Hong Kong listing in June 2025. That application expired six months later, NewTimeSpace reported in December 2025.

Sources
1MegaRobo's November 18 financing announcement ↗
2Leidi via Sina: MegaRobo's June 2025 listing-application coverage ↗
336Kr: MegaRobo's financing and research services ↗
4MegaRobo's June 2022 Series C announcement ↗
5NewTimeSpace: MegaRobo's listing application expires ↗
6Notice: MegaRobo's private-company status ↗